Restrictive Lung Disease
13
1
1
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
15%
2 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (13)
The Effect of Spinal Mobilization on Respiratory Parameters in Parkinson's Disease Patients
Thoracic Mobilization for Restrictive Lung Disease
From Inflammation to Remodelling Towards Personalized Diagnosis in Post-acute Sequelae of COVID-19
Relation Between Pulmonary Function Tests and Ultrasonographic Chest Joints
Cardio-pulmonary Rehabilitation and Sleep Quality
Renal- and Pulmonary Function in Relation to Abdominal Hypertension After Abdominal Reconstruction
COVID-19 Pneumonia: Pulmonary Physiology, Health-related Quality of Life and Benefit of a Rehabilitation Program
The Debated Role of Sleep Studies in Patients Under Established Home Mechanical Ventilation
Evaluation of the Respiratory Impact After Conventional or Minimally Invasive Esophageal Atresia Surgery
Database of All Patients Who Have Undergone Pulmonary Function Testing at Singapore General Hospital
Lung Function Decline and Disease Risk From Young Adulthood to Middle Age
Effects of Dexmedetomidine on Oxygenation and Lung Mechanics in Morbidly Obese Patients Undergoing Bariatric Operations
Improving Clinician Communication Skills (ICCS)